Charles Schwab’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-66,565
| Closed | -$38.6K | – | 3546 |
|
|
2024
Q3 | $38.6K | Hold |
66,565
| – | – | ﹤0.01% | 3438 |
|
|
2024
Q2 | $41.1K | Sell |
66,565
-200,640
| -75% | -$170K | ﹤0.01% | 3529 |
|
|
2024
Q1 | $687K | Hold |
267,205
| – | – | ﹤0.01% | 2911 |
|
|
2023
Q4 | $545K | Buy |
267,205
+66,565
| +33% | +$122K | ﹤0.01% | 3048 |
|
|
2023
Q3 | $345K | Sell |
200,640
-34,009
| -14% | -$60.4K | ﹤0.01% | 3191 |
|
|
2023
Q2 | $458K | Buy |
234,649
+200,640
| +590% | +$470K | ﹤0.01% | 3096 |
|
|
2023
Q1 | $94.5K | Hold |
34,009
| – | – | ﹤0.01% | 3259 |
|
|
2022
Q4 | $117K | Buy |
34,009
+12,609
| +59% | +$36K | ﹤0.01% | 3243 |
|
|
2022
Q3 | $55K | Hold |
21,400
| – | – | ﹤0.01% | 3310 |
|
|
2022
Q2 | $52K | Sell |
21,400
-93,946
| -81% | -$247K | ﹤0.01% | 3388 |
|
|
2022
Q1 | $476K | Buy |
115,346
+1,359
| +1% | +$7.2K | ﹤0.01% | 3116 |
|
|
2021
Q4 | $1.47M | Buy |
113,987
+11,617
| +11% | +$129K | ﹤0.01% | 2789 |
|
|
2021
Q3 | $1.11M | Sell |
102,370
-76,951
| -43% | -$700K | ﹤0.01% | 2837 |
|
|
2021
Q2 | $1.64M | Buy |
179,321
+24,157
| +16% | +$223K | ﹤0.01% | 2784 |
|
|
2021
Q1 | $1.46M | Buy |
155,164
+13,653
| +10% | +$188K | ﹤0.01% | 2733 |
|
|
2020
Q4 | $558K | Buy |
141,511
+1,975
| +1% | +$5.97K | ﹤0.01% | 2953 |
|
|
2020
Q3 | $370K | Sell |
139,536
-5,207
| -4% | -$19.3K | ﹤0.01% | 2966 |
|
|
2020
Q2 | $962K | Buy |
144,743
+19,461
| +16% | +$131K | ﹤0.01% | 2641 |
|
|
2020
Q1 | $730K | Buy |
125,282
+1,773
| +1% | +$14.9K | ﹤0.01% | 2574 |
|
|
2019
Q4 | $1.11M | Buy |
123,509
+1,257
| +1% | +$10.5K | ﹤0.01% | 2562 |
|
|
2019
Q3 | $1.06M | Buy |
122,252
+1,465
| +1% | +$14.8K | ﹤0.01% | 2550 |
|
|
2019
Q2 | $1.35M | Buy |
120,787
+81,444
| +207% | +$931K | ﹤0.01% | 2483 |
|
|
2019
Q1 | $524K | Buy |
39,343
+632
| +2% | +$8.45K | ﹤0.01% | 2748 |
|
|
2018
Q4 | $599K | Buy |
+38,711
| New | +$739K | ﹤0.01% | 2705 |
|
Other funds holding GRTS
Charles Schwab's GRTS Position: Q4 2024 in Review
Charles Schwab sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 66,565 shares — an estimated $38.6K sold.
Charles Schwab first reported a position in GRTS in Q4 2018 and held it in 24 quarters. The position peaked at $1.64M in Q2 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- Charles Schwab reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Charles Schwab sold 66,565 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $38.6K.
- Charles Schwab first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
- Charles Schwab's Gritstone bio, Inc. Common Stock position peaked at $1.64M in Q2 2021.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.